Viatris Inc. (Viatris) is a global healthcare company. The company’s divisions are Developed Markets, Greater China, JANZ and Emerging Markets. The Developed Markets segment has operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ division has operations in Japan, Australia and New Zealand. The Emerging Markets segment includes developing markets and emerging economies in more than 125 countries and the company’s ARV franchise. The portfolio includes more than 1,400 approved molecules across several key therapeutic areas, including leading brands and complex generics. The company has around 40 manufacturing sites worldwide. Its products include Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen Auto Injector, Fraxiparine and Yupelri.
Learn more about the company
Harper Lee is a contributor at Thecherawchronicle.com, covering a wide range of topics including news, politics, business, technology, sports, entertainment, and lifestyle. With a focus on clear reporting and useful information, Harper delivers timely coverage of current events and developments that matter to readers. Her work emphasizes accuracy, context, and accessibility, helping audiences stay informed about important stories, emerging trends, and issues affecting communities in the United States and beyond.
More Stories
Powerful Winter Storm Expected to Hit Minnesota This Weekend
KC-135 Tanker Linked to Deadly Iraq Crash Connected to Aircraft From Beale Air Force Base
Senate Push to Limit Trump’s Iran War Powers as Conflict Expected to Last Weeks